Table 3.
50–59 y. (n = 447) N (%) |
60–69 y. (n = 474) N (%) |
70–79 y. (n = 318) N (%) |
80–89 y. (n = 120) N (%) |
P-valuea | |
---|---|---|---|---|---|
Cardiovascular disease (CVD)b | 34 (7.6) | 57 (12.0) | 64 (20.1) | 31 (25.8) | 0.006 |
Ischaemic heart disease | 0 (0.0) | 0 (0.0) | 1 (0.3) | 2 (1.7) | 0.013 |
Myocardial infarction | 5 (1.1) | 17 (3.6) | 12 (3.8) | 5 (4.2) | 0.030 |
Angina pectoris | 1 (0.2) | 5 (1.1) | 14 (4.4) | 7 (5.8) | <0.001 |
Percutaneous coronary intervention | 6 (1.3) | 14 (3.0) | 9 (2.8) | 4 (3.3) | NS |
Coronary bypass | 3 (0.7) | 6 (1.3) | 10 (3.1) | 3 (2.5) | 0.038 |
Cerebrovascular accident | 10 (2.2) | 6 (1.3) | 17 (5.3) | 11 (9.2) | <0.001 |
Transient ischaemic attack | 7 (1.6) | 10 (2.1) | 10 (3.1) | 8 (6.7) | 0.024 |
Peripheral artery disease | 7 (1.6) | 13 (2.7) | 13 (4.1) | 7 (5.8) | 0.040 |
Venous thromboembolic events (VTE)c | 4 (0.9) | 7 (1.5) | 7 (2.2) | 5 (4.2) | NS |
Venous thromboembolism | 3 (0.7) | 6 (1.3) | 4 (1.3) | 2 (1.7) | NS |
Pulmonary embolism | 2 (0.4) | 1 (0.2) | 3 (0.9) | 4 (3.3) | 0.009 |
Hypertension (HT) | 49 (11.0) | 65 (13.7) | 60 (18.9) | 28 (23.3) | 0.001 |
Diabetes mellitus type 2 (DM2) | 16 (3.6) | 42 (8.9) | 27 (8.9) | 11 (9.2) | 0.006 |
CVD or VTE | 37 (8.3) | 62 (13.1) | 67 (21.1) | 34 (28.3) | <0.001 |
CVD or VTE or HT | 81 (18.1) | 120 (25.3) | 105 (33.0) | 54 (45.0) | <0.001 |
CVD or VTE or HT or DM2 | 93 (20.8) | 142 (30.0) | 114 (35.8) | 58 (48.3) | <0.001 |
aFisher's exact test.
bCardiovascular disease: having ischaemic heart disease or myocardial infarction or angina pectoris or percutaneous coronary intervention or bypass or cerebrovascular accident or transient ischaemic attack or peripheral artery disease in medical history.
cVenous thromboembolic events: having venous thromboembolism or pulmonary thromboembolism in medical history.